Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00016887
What this trial is testing

Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

Who this might be right for
Lymphoma
German Low Grade Lymphoma Study Group
Early research (Phase 1)Study completedNCT01822509
What this trial is testing

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientMyeloproliferative NeoplasmRecurrent Acute Lymphoblastic Leukemia+8 more
National Cancer Institute (NCI) 71
Large-scale testing (Phase 3)Active Not RecruitingNCT02659293
What this trial is testing

Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Chicago 180
Testing effectiveness (Phase 2)WithdrawnNCT00005998
What this trial is testing

Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
Lymphoma
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)UnknownNCT03091933
What this trial is testing

Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)

Who this might be right for
Hematologic CancerRelapse LeukemiaRelapsed Adult ALL+6 more
Ciusss de L'Est de l'Île de Montréal 20
Testing effectiveness (Phase 2)Study completedNCT05991973
What this trial is testing

Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

Who this might be right for
T Lymphoblastic Leukemia/Lymphoma
Zhejiang University 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06411184
What this trial is testing

Safety and Efficacy of Treg Cell in the Treatment of GVHD

Who this might be right for
GVHD
Xuzhou Medical University 20
Testing effectiveness (Phase 2)Study completedNCT00619684
What this trial is testing

Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Transplant

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00144703
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

Who this might be right for
Hematologic MalignanciesMyelogenous LeukemiaAcute Lymphoblastic Leukemia+3 more
Dana-Farber Cancer Institute 55
Testing effectiveness (Phase 2)Study completedNCT07319000
What this trial is testing

Efficacy of Low-dose PT-Cy for Prevention of GVHD in Ambulatory Allogeneic HSCT

Who this might be right for
Graft Versus Host Disease
Hospital Universitario Dr. Jose E. Gonzalez 35
Early research (Phase 1)Study completedNCT01026987
What this trial is testing

Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant

Who this might be right for
Stem Cell Transplant Patients
Washington University School of Medicine 29
Large-scale testing (Phase 3)Study completedNCT00138112
What this trial is testing

Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation

Who this might be right for
Streptococcal SepsisHematologic Malignancies
Memorial Sloan Kettering Cancer Center 126
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Testing effectiveness (Phase 2)Study completedNCT00003145
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia

Who this might be right for
Accelerated Phase of DiseaseChildhood Chronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Myelogenous Leukemia, BCR-ABL1 Positive+2 more
Fred Hutchinson Cancer Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05796570
What this trial is testing

A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyeloid Malignancies+4 more
Franziska Wachter 29
Testing effectiveness (Phase 2)Ended earlyNCT00632827
What this trial is testing

Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)

Who this might be right for
Peripheral T-Cell Lymphoma
University of California, San Francisco 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07608029
What this trial is testing

Xiaochaihu Granules for Depression After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Depressive Disorder, SecondaryHematopoietic Stem Cell Transplantation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 46
Early research (Phase 1)WithdrawnNCT06572631
What this trial is testing

Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched Donor

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic SyndromeRefractory Acute Myeloid Leukemia+1 more
City of Hope Medical Center
Not applicableUnknownNCT06022445
What this trial is testing

Prospective Validation of CARPET Prognostic Model for Septic Shock After Allo-HSCT

Who this might be right for
Stem Cell Transplant Complications
Peking University People's Hospital 200
Not applicableStudy completedNCT00956475
What this trial is testing

Quality of Life in Younger Leukemia and Lymphoma Survivors

Who this might be right for
Anxiety DisorderCancer SurvivorFatigue+7 more
Case Comprehensive Cancer Center 48
Next Page